EyePromise, the industry-leading eye health nutraceutical company, has announced the latest updates to its comprehensive nutritional program for eyecare practices. With an eye towards innovation and ...
and Japan's Ministry of Health, Labour and Welfare (MHLW) each approved EYLEA 8 mg (known as EYLEA HD in the United States) for the treatment of patients with wet age-related macular degeneration ...
AMD Stopper Inc. is a newly organized company which holds the formulas, patent applications, and intellectual property rights to the formula developed by an eye care researcher to treat Age-Related ...
In 2032, the global lutein market, which is currently valued at US$ 354.3 million, is anticipated to reach US$ 590 million, ...
Business and Financial Times on MSN11d
Ginkgo Biloba – potential natural glaucoma treatment
By Prof. Raphael Nyarkotey OBUQuaranta et al.(2003) found evidence that Ginkgo biloba may have a benefit in the treatment of ...
First quarter 2024 revenues decreased 1% to $3.15 billion versus first quarter 2023; excluding RonapreveTM(a)(b), revenues increased 7%First quarter 2024 Dupixent® global net sales (recorded by Sanofi ...